A randomized phase II trial of three intensified chemotherapy regimens in first-line treatment of colorectal cancer patients with initially unresectable or not optimally resectable liver metastases. The METHEP trial.

A randomized phase II trial of three intensified chemotherapy regimens in first-line treatment of colorectal cancer patients with initially unresectable or not optimally resectable liver metastases. The METHEP trial.

Item
http://www.wikidata.org/entity/Q39365352
Multisciplinary management of patients with liver metastasis from colorectal cancerMultidisciplinary approach of colorectal cancer liver metastases.Lean body mass as an independent determinant of dose-limiting toxicity and neuropathy in patients with colon cancer treated with FOLFOX regimens.MicroRNA-203 predicts human survival after resection of colorectal liver metastasis.The pharmacological costs of complete liver resections in unselected advanced colorectal cancer patients: a review of published Phase II and III trials.Bevacizumab plus mFOLFOX-6 or FOLFOXIRI in patients with initially unresectable liver metastases from colorectal cancer: the OLIVIA multinational randomised phase II trial.Phase II Trial of S-1 and Oxaliplatin Plus Cetuximab for Colorectal Cancer Patients with Initially Unresectable or Not Optimally Resectable Liver Metastases (KSCC1002).A Review of Clinical Studies and Practical Guide for the Administration of Triplet Chemotherapy Regimens with Bevacizumab in First-line Metastatic Colorectal CancerHepatic arterial infusion plus systemic chemotherapy as third-line or later treatment in colorectal liver metastases.Liposomal 64Cu-PET Imaging of Anti-VEGF Drug Effects on Liposomal Delivery to Colon Cancer Xenografts.Drug resistance related to aberrant glycosylation in colorectal cancer.Prognostic factors of hepatectomy in initially unresectable colorectal liver metastasis: Indication for conversion therapy
P2860

A randomized phase II trial of three intensified chemotherapy regimens in first-line treatment of colorectal cancer patients with initially unresectable or not optimally resectable liver metastases. The METHEP trial.

Item
http://www.wikidata.org/entity/Q39365352
description
2013 nî lūn-bûn
@nan
2013年の論文
@ja
2013年学术文章
@wuu
2013年学术文章
@zh-cn
2013年学术文章
@zh-hans
2013年学术文章
@zh-my
2013年学术文章
@zh-sg
2013年學術文章
@yue
2013年學術文章
@zh
2013年學術文章
@zh-hant
name
A randomized phase II trial of ...... metastases. The METHEP trial.
@en
A randomized phase II trial of ...... metastases. The METHEP trial.
@nl
type
label
A randomized phase II trial of ...... metastases. The METHEP trial.
@en
A randomized phase II trial of ...... metastases. The METHEP trial.
@nl
prefLabel
A randomized phase II trial of ...... metastases. The METHEP trial.
@en
A randomized phase II trial of ...... metastases. The METHEP trial.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P6179
P698
P921
P356
P1433
P1476
A randomized phase II trial of ...... r metastases. The METHEP trial
@en
P2093
P2860
P2888
P304
P31
P356
P433
P478
P50
P577
P5875
P6179
P698
P921